Fenretinide May Benefit Patients With Dry AMD

The UK’s Daily Mail Share to FacebookShare to Twitter (10/18, Macrae) reports that fenretinide, “a drug based on vitamin A, could prevent millions from going blind” due to dry age-related macular degeneration (AMD), according to research presented at an ophthalmology conference. In a study of nearly 250 patients with dry AMD who were randomized to fenretinide or to placebo, researchers found that “in the highest dose, the drug halted visual deterioration after a year. This suggests that while it was unable to do anything to stop cells that were already damaged from dying, it protected healthy cells.”

Bloomberg News Share to FacebookShare to Twitter (10/17, Olmos) reported, “The drug is believed to slow the progression of macular degeneration by reducing inflammation, inhibiting abnormal growth of blood vessels, and reducing levels of vitamin A in the retina, which can cause the formation of lesions that impair vision in people with the disease.”

Courtesy of the Doctors at Shady Grove Eye and Vision Care; Optometrists, Ophthalmologists and Opticians working together to help you see better.  Serving the Rockville, Potomac and Gaithersburg Maryland suburbs of Washington, DC for over 40 years. For more information visit youreyesite.com or call (301) 670-1212

Connect with us on Twitter @EyeInfo and subscribe (free subscription) to this blog

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: